Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
3
×
new york blog main
3
×
biotech
boston blog main
clinical trials
new york
new york top stories
san francisco blog main
san francisco top stories
23andme
alirocumab
allergan
alnylam pharmaceuticals
alphabet
american academy of ophthalmology
amgen
analytics
big data
biomatics capital
boston top stories
boulder/denver blog main
bristol-myers squibb
brook byers
clinical data
digisight
drug development
drugs
evercore isi
evolocumab
ge ventures
genfit
gilead sciences
glaxosmithkline
gv
health it
heart attack
inclisiran
intercept pharmaceuticals
investing
What
data
3
×
new
3
×
drug
adds
alnylam
analyzes
approved
based
ceo
cholesterol
company
developing
devices
disease
drugs
electronic
evidence
fatty
financing
gv
health
heart
horizon
insights
intercept
kapoor
known
lands
lasting
led
liver
long
looms
lowering
marketed
medco
medical
medicine
medicines
miki
Language
Current search:
data
×
new
×
" national blog main "
×
" new york blog main "
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
